期刊文献+

疏肝柴胡散联合胆舒胶囊及消炎利胆片治疗胆囊切除术后综合征临床评价 被引量:8

Clinical Evaluation on Shugan Chaihu Powder Combined with Danshu Capsules and Xiaoyan Lidan Tablets in the Treatment of Postcholecystectomy Syndrome
暂未订购
导出
摘要 目的观察疏肝柴胡散联合胆舒胶囊和消炎利胆片治疗胆囊切除术后综合征(PCS)的临床疗效及安全性。方法选取医院2016年1月至2018年1月收治的PCS患者200例,按随机数字表法分为对照组和研究组,各100例。两组患者均予对症治疗,并口服胆舒胶囊及消炎利胆片,研究组患者加服疏肝柴胡散;两组患者均治疗1个月。结果研究组总有效率为98. 00%,显著高于对照组的77. 00%(P <0. 05);与治疗前比较,两组患者治疗后的白细胞介素6(IL-6)、C反应蛋白(CRP)水平均显著降低,且研究组显著低于对照组(P <0. 05);两组患者治疗后的肝、肾功能指标均无显著变化(P> 0. 05);两组治疗期间均未出现不良反应。结论疏肝柴胡散联合胆舒胶囊和消炎利胆片治疗PCS疗效确切,可减轻炎性反应,且不影响肝肾功能。 Objective To observe the clinical effect and safety of Shugan Chaihu Powder combined with Danshu Capsules and Xiaoyan Lidan Tablets in the treatment of postcholecystectomy syndrome(PCS).Methods Totally 200 patients with PCS admitted to our hospital from January 2016 to January 2018 were selected and divided into the control group and the study group according to the random number table method,100 cases in each group.The patients in the two groups were given symptomatic treatment and oral administration of Danshu Capsules and Xiaoyan Lidan Tablets,on this basis,the patients in the study group were given Shugan Chaihu Powder.The patients in the two groups were treated for 1 month.Results The total effective rate of the study group was 98.00%,which was significantly higher than 77.00% of the control group(P<0.05).Compared with before treatment,the levels of interleukin-6(IL-6)and C-reactive protein(CRP)in the two groups were significantly decreased after treatment,and those in the study group were significantly lower than those in the control group(P<0.05).There was no significant change in liver and kidney function after treatment in the two groups(P>0.05).There was no adverse reaction during treatment in the two groups.Concllisiion Shugan Chaihu Powder combined with Danshu Capsules and Xiaoyan Lidan Tablets are effective in the treatment of PCS,which can alleviate inflammatory reaction without affecting liver and kidney function.
作者 郝少欢 徐祺林 HAO Shaohuan;XU Qilin(The First People's Hospital of Kashi Prefecture,Kashi,Xinjiang,China 844000)
出处 《中国药业》 CAS 2019年第8期44-46,共3页 China Pharmaceuticals
基金 新疆维吾尔自治区卫生计生委青年科技人才专项科研项目[2016Y35]
关键词 疏肝柴胡散 胆舒胶囊 消炎利胆片 胆囊切除术后综合征 临床疗效 安全性 Shugan Chaihu Powder Danshu Capsules Xiaoyan Lidan Tablets postcholecystectomy syndrome clinical effect safety
  • 相关文献

参考文献11

二级参考文献199

共引文献182

同被引文献154

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部